2Seventy Bio Inc (TSVT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-19 | 2025-03-17 | S Sale |
Chief Financial Officer Officer |
2,592
-0.6%
4.95USD 12,817 |
2,592 -0.6% | 4.95 | USD 12,817 | |
| 2025-03-19 | 2025-03-17 | S Sale |
President and CEO Executive Director |
5,092
-0.5%
4.95USD 25,180 |
5,092 -0.5% | 4.95 | USD 25,180 | |
| 2025-03-19 | 2025-03-17 | S Sale |
Chief Operating Officer Officer |
2,298
-0.9%
4.95USD 11,364 |
2,298 -0.9% | 4.95 | USD 11,364 | |
| 2025-03-13 | 2025-03-11 | S Sale |
Kynam Global Healthcare Master Fund, LP Large shareholder |
5,142,111
-100.0%
4.93USD 25,350,607 |
5,142,111 -100.0% | 4.93 | USD 25,350,607 | |
| 2025-03-13 | 2025-03-11 | S Sale |
Kynam Global Healthcare Master Fund, LP Large shareholder |
5,142,111
-100.0%
4.93USD 25,350,607 |
5,142,111 -100.0% | 4.93 | USD 25,350,607 | |
| 2025-03-13 | 2025-03-11 | S Sale |
Kynam Global Healthcare Master Fund, LP Large shareholder |
5,953,825
-100.0%
4.93USD 29,352,357 |
5,953,825 -100.0% | 4.93 | USD 29,352,357 | |
| 2025-01-07 | 2025-01-07 | PS Planned sale |
See Remarks Officer |
186
-0.1%
2.64USD 491 |
186 -0.1% | 2.64 | USD 491 | |
| 2025-01-07 | 2025-01-06 | S Sale | Non-Executive Director |
892
-0.1%
2.78USD 2,478 |
892 -0.1% | 2.78 | USD 2,478 | |
| 2025-01-07 | 2025-01-06 | PS Planned sale |
See Remarks Officer |
5,000
-3.3%
2.79USD 13,972 |
5,000 -3.3% | 2.79 | USD 13,972 | |
| 2025-01-07 | 2025-01-06 | S Sale |
See Remarks Officer |
114
-0.1%
2.78USD 317 |
114 -0.1% | 2.78 | USD 317 | |
| 2025-01-07 | 2025-01-06 | S Sale |
President and CEO Executive Director |
763
-0.1%
2.78USD 2,120 |
763 -0.1% | 2.78 | USD 2,120 | |
| 2025-01-07 | 2025-01-06 | S Sale |
Chief Financial Officer Officer |
97
-0.0%
2.78USD 270 |
97 -0.0% | 2.78 | USD 270 | |
| 2025-01-07 | 2025-01-03 | S Sale | Non-Executive Director |
85,978
-6.5%
2.94USD 252,423 |
85,978 -6.5% | 2.94 | USD 252,423 | |
| 2025-01-07 | 2025-01-03 | S Sale |
See Remarks Officer |
1,000
-0.7%
2.94USD 2,936 |
1,000 -0.7% | 2.94 | USD 2,936 | |
| 2025-01-07 | 2025-01-03 | S Sale |
President and CEO Executive Director |
31,718
-3.5%
2.94USD 93,121 |
31,718 -3.5% | 2.94 | USD 93,121 | |
| 2025-01-07 | 2025-01-03 | S Sale |
Chief Financial Officer Officer |
1,013
-0.3%
2.94USD 2,974 |
1,013 -0.3% | 2.94 | USD 2,974 | |
| 2024-12-17 | 2024-12-13 | PS Planned sale |
See Remarks Officer |
2,287
-1.5%
3.23USD 7,393 |
2,287 -1.5% | 3.23 | USD 7,393 | |
| 2024-11-20 | 2024-11-18 | S Sale | Non-Executive Director |
3,900
-14.1%
3.38USD 13,182 |
3,900 -14.1% | 3.38 | USD 13,182 | |
| 2024-10-07 | 2024-10-03 | PS Planned sale |
See Remarks Officer |
679
-0.4%
4.65USD 3,157 |
679 -0.4% | 4.65 | USD 3,157 | |
| 2024-10-07 | 2024-10-03 | S Sale |
Chief Financial Officer Officer |
1,230
-0.4%
4.65USD 5,718 |
1,230 -0.4% | 4.65 | USD 5,718 | |
| 2024-08-16 | 2024-08-14 | S Sale |
See Remarks Officer |
7,816
-4.8%
4.32USD 33,760 |
7,816 -4.8% | 4.32 | USD 33,760 | |
| 2024-08-07 | 2024-08-05 | S Sale |
Chief Financial Officer Officer |
13
-0.0%
3.99USD 52 |
13 -0.0% | 3.99 | USD 52 | |
| 2024-07-03 | 2024-07-02 | S Sale |
Chief Financial Officer Officer |
12
-0.0%
4.02USD 48 |
12 -0.0% | 4.02 | USD 48 | |
| 2024-07-03 | 2024-07-02 | S Sale |
See Remarks Officer |
14
-0.0%
4.02USD 56 |
14 -0.0% | 4.02 | USD 56 | |
| 2024-06-05 | 2024-06-03 | S Sale |
See Remarks Officer |
649
-1.2%
4.18USD 2,714 |
649 -1.2% | 4.18 | USD 2,714 | |
| 2024-06-05 | 2024-06-03 | S Sale |
Chief Financial Officer Officer |
1,167
-1.2%
4.18USD 4,881 |
1,167 -1.2% | 4.18 | USD 4,881 | |
| 2024-05-16 | 2024-05-03 | S Sale |
See Remarks Officer |
15
-0.0%
4.91USD 74 |
15 -0.0% | 4.91 | USD 74 | |
| 2024-03-28 | 2024-03-26 | B Purchase | Non-Executive Director |
40,000
+2.0%
5.10USD 203,992 |
40,000 +2.0% | 5.10 | USD 203,992 | |
| 2024-03-25 | 2024-03-25 | B Purchase | Non-Executive Director |
330,000
+20.2%
5.07USD 1,673,991 |
330,000 +20.2% | 5.07 | USD 1,673,991 | |
| 2024-03-25 | 2024-03-22 | B Purchase | Non-Executive Director |
147,377
+9.9%
5.12USD 754,069 |
147,377 +9.9% | 5.12 | USD 754,069 | |
| 2024-03-25 | 2024-03-21 | B Purchase | Non-Executive Director |
300,000
+25.4%
4.90USD 1,470,990 |
300,000 +25.4% | 4.90 | USD 1,470,990 | |
| 2024-01-09 | 2024-01-05 | S Sale |
Chief Scientific Officer Officer |
795
-0.3%
3.75USD 2,984 |
795 -0.3% | 3.75 | USD 2,984 | |
| 2024-01-09 | 2024-01-05 | S Sale |
Chief Operating Officer Officer |
1,380
-0.8%
3.75USD 5,180 |
1,380 -0.8% | 3.75 | USD 5,180 | |
| 2024-01-09 | 2024-01-05 | S Sale |
President and CEO Executive Director |
1,554
-0.1%
3.75USD 5,833 |
1,554 -0.1% | 3.75 | USD 5,833 | |
| 2024-01-05 | 2024-01-03 | S Sale |
Chief Scientific Officer Officer |
25,613
-10.0%
3.87USD 99,084 |
25,613 -10.0% | 3.87 | USD 99,084 | |
| 2024-01-05 | 2024-01-03 | S Sale |
President and CEO Executive Director |
72,312
-6.2%
3.87USD 279,739 |
72,312 -6.2% | 3.87 | USD 279,739 | |
| 2024-01-05 | 2024-01-03 | S Sale |
Chief Operating Officer Officer |
33,651
-17.1%
3.87USD 130,179 |
33,651 -17.1% | 3.87 | USD 130,179 | |
| 2023-08-24 | 2023-08-22 | S Sale |
Chief Financial Officer Officer |
7,031
-3.5%
5.49USD 38,576 |
7,031 -3.5% | 5.49 | USD 38,576 | |
| 2023-08-24 | 2023-08-22 | S Sale |
President and CEO Executive Director |
9,312
-0.8%
5.49USD 51,090 |
9,312 -0.8% | 5.49 | USD 51,090 | |
| 2023-08-24 | 2023-08-22 | S Sale |
Chief Scientific Officer Officer |
6,159
-2.3%
5.49USD 33,791 |
6,159 -2.3% | 5.49 | USD 33,791 | |
| 2023-08-16 | 2023-08-10 | B Purchase |
Kynam Global Healthcare Master Fund, LP Large shareholder |
86,414
+1.7%
5.96USD 515,027 |
86,414 +1.7% | 5.96 | USD 515,027 | |
| 2023-08-16 | 2023-08-10 | B Purchase |
Kynam Global Healthcare Master Fund, LP Large shareholder |
86,414
+1.7%
5.96USD 515,027 |
86,414 +1.7% | 5.96 | USD 515,027 | |
| 2023-08-16 | 2023-08-10 | B Purchase |
Kynam Global Healthcare Master Fund, LP Large shareholder |
100,000
+1.7%
5.96USD 596,000 |
100,000 +1.7% | 5.96 | USD 596,000 | |
| 2023-08-16 | 2023-08-10 | B Purchase |
Kynam Global Healthcare Master Fund, LP Large shareholder |
100,000
+1.7%
5.85USD 585,000 |
100,000 +1.7% | 5.85 | USD 585,000 | |
| 2023-08-16 | 2023-08-10 | B Purchase |
Kynam Global Healthcare Master Fund, LP Large shareholder |
50,000
+0.9%
5.80USD 290,000 |
50,000 +0.9% | 5.80 | USD 290,000 | |
| 2023-08-16 | 2023-08-10 | B Purchase |
Kynam Global Healthcare Master Fund, LP Large shareholder |
179,000
+3.2%
5.94USD 1,063,260 |
179,000 +3.2% | 5.94 | USD 1,063,260 | |
| 2023-08-14 | 2023-08-10 | B Purchase | Large shareholder |
86,414
+1.7%
5.96USD 515,027 |
86,414 +1.7% | 5.96 | USD 515,027 | |
| 2023-08-14 | 2023-08-10 | B Purchase | Large shareholder |
86,414
+1.7%
5.96USD 515,027 |
86,414 +1.7% | 5.96 | USD 515,027 | |
| 2023-08-14 | 2023-08-10 | B Purchase | Large shareholder |
100,000
+1.7%
5.96USD 596,000 |
100,000 +1.7% | 5.96 | USD 596,000 | |
| 2023-08-14 | 2023-08-10 | B Purchase | Large shareholder |
100,000
+1.7%
5.85USD 585,000 |
100,000 +1.7% | 5.85 | USD 585,000 | |
| 2023-08-14 | 2023-08-10 | B Purchase | Large shareholder |
50,000
+0.9%
5.80USD 290,000 |
50,000 +0.9% | 5.80 | USD 290,000 | |
| 2023-08-14 | 2023-08-10 | B Purchase | Large shareholder |
179,000
+3.2%
5.94USD 1,063,260 |
179,000 +3.2% | 5.94 | USD 1,063,260 | |
| 2023-08-07 | 2023-08-03 | S Sale |
Chief Scientific Officer Officer |
3,966
-1.5%
6.13USD 24,295 |
3,966 -1.5% | 6.13 | USD 24,295 | |
| 2023-08-07 | 2023-08-03 | S Sale |
President and CEO Executive Director |
9,060
-0.8%
6.13USD 55,499 |
9,060 -0.8% | 6.13 | USD 55,499 | |
| 2023-08-07 | 2023-08-03 | S Sale |
Chief Financial Officer Officer |
6,906
-3.3%
6.13USD 42,304 |
6,906 -3.3% | 6.13 | USD 42,304 | |
| 2023-02-15 | 2023-02-13 | S Sale |
Chief Financial Officer Officer |
637
-0.3%
12.86USD 8,192 |
637 -0.3% | 12.86 | USD 8,192 | |
| 2023-02-09 | 2023-02-07 | S Sale |
Chief Operating Officer Officer |
60
-0.1%
14.70USD 882 |
60 -0.1% | 14.70 | USD 882 | |
| 2023-01-17 | 2023-01-12 | S Sale |
President and CEO Executive Director |
6,587
-1.2%
10.46USD 68,889 |
6,587 -1.2% | 10.46 | USD 68,889 | |
| 2023-01-18 | 2023-01-11 | S Sale |
Chief Operating Officer Officer |
128
-0.1%
10.63USD 1,360 |
128 -0.1% | 10.63 | USD 1,360 | |
| 2023-01-18 | 2023-01-11 | S Sale |
Chief Scientific Officer Officer |
1,076
-1.1%
10.63USD 11,436 |
1,076 -1.1% | 10.63 | USD 11,436 | |
| 2023-01-18 | 2023-01-11 | S Sale |
Chief Financial Officer Officer |
1,077
-1.3%
10.63USD 11,446 |
1,077 -1.3% | 10.63 | USD 11,446 | |
| 2023-01-18 | 2023-01-11 | S Sale |
President and CEO Executive Director |
2,026
-0.4%
10.63USD 21,533 |
2,026 -0.4% | 10.63 | USD 21,533 | |
| 2023-01-11 | 2023-01-09 | S Sale |
Chief Scientific Officer Officer |
3,794
-3.6%
10.33USD 39,210 |
3,794 -3.6% | 10.33 | USD 39,210 | |
| 2023-01-11 | 2023-01-09 | S Sale |
President and CEO Executive Director |
2,979
-0.5%
10.33USD 30,787 |
2,979 -0.5% | 10.33 | USD 30,787 | |
| 2023-01-11 | 2023-01-09 | S Sale |
Chief Operating Officer Officer |
584
-0.6%
10.33USD 6,035 |
584 -0.6% | 10.33 | USD 6,035 | |
| 2023-01-11 | 2023-01-09 | S Sale |
Chief Financial Officer Officer |
3,222
-3.9%
10.33USD 33,298 |
3,222 -3.9% | 10.33 | USD 33,298 | |
| 2022-12-06 | 2022-12-05 | S Sale |
Chief Operating Officer Officer |
272
-0.3%
15.43USD 4,198 |
272 -0.3% | 15.43 | USD 4,198 | |
| 2022-11-23 | 2022-11-21 | S Sale |
Chief Operating Officer Officer |
7,697
-7.9%
13.97USD 107,527 |
7,697 -7.9% | 13.97 | USD 107,527 | |
| 2022-08-08 | 2022-08-05 | S Sale |
Chief Scientific Officer Officer |
2,407
-2.3%
16.23USD 39,072 |
2,407 -2.3% | 16.23 | USD 39,072 | |
| 2022-08-08 | 2022-08-05 | S Sale |
President and CEO Executive Director |
5,499
-1.0%
16.23USD 89,263 |
5,499 -1.0% | 16.23 | USD 89,263 | |
| 2022-08-08 | 2022-08-05 | S Sale |
Chief Financial Officer Officer |
4,152
-4.8%
16.23USD 67,397 |
4,152 -4.8% | 16.23 | USD 67,397 | |
| 2022-07-19 | 2022-07-15 | S Sale |
President and CEO Executive Director |
5,404
-1.0%
13.81USD 74,629 |
5,404 -1.0% | 13.81 | USD 74,629 | |
| 2022-07-19 | 2022-07-15 | S Sale |
Chief Financial Officer Officer |
4,080
-4.5%
13.81USD 56,344 |
4,080 -4.5% | 13.81 | USD 56,344 | |
| 2022-07-19 | 2022-07-15 | S Sale |
Chief Scientific Officer Officer |
2,365
-2.2%
13.81USD 32,660 |
2,365 -2.2% | 13.81 | USD 32,660 | |
| 2022-02-22 | 2022-02-17 | S Sale |
Chief Financial Officer Officer |
427
-0.7%
14.78USD 6,311 |
427 -0.7% | 14.78 | USD 6,311 |